Plenary Session - inactive due to federal service
A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California, San Francisco.
Tweet your feedback to @Plenary_Session or e-mail [email protected].
- Update frequency
- every 6 days
- Average duration
- 64 minutes
- Episodes
- 397
- Years Active
- 2018 - 2025
5.06 - POLO trial now has OS results - OMG
The POLO trial, which we first broke on PS Season 1- is back with null OS results. But the trial authors enter the spin cycle. VP goes line by line.
00:30:40 |
Thu 21 Jul 2022
5.05 - Citations, Metrics, Rankings in Oncology & Medicine
VP explains H index, total cites, papers, US News and World Report rankings and how evaluates researchers and doctors.
00:36:38 |
Mon 18 Jul 2022
5.04 - Echelon 1 reports OS benefit - But does it add up?
VP addresses what to do you if you get an idea from listening to the show, and deconstructs ECHELON-1. Instead of listening we highly recommend you watch the video on YouTube with graphics. This is …
00:39:12 |
Thu 14 Jul 2022
5.03 - VPs Grand Rounds Lecture - Evidence Based Medicine - Will it Survive?
How to think about when and how to do RCTs? What are the limitations to observational studies? Smoking. Parachutes. Dostarlimab. Guarantee Time Bias. Confounding. Multiple Hypothesis testing and mo…
00:51:07 |
Wed 13 Jul 2022
5.02 - Listener Questions - Cancer & Evidence Philosophy - What this Pod Offers
I make the case why this podcast should be your go to for Med, Onc & Policy. I describe my philosophy of Evidence, Empiricism, and show how this connects to many oncology studies. I answer a bunch …
00:46:31 |
Mon 11 Jul 2022
5.01 - How To Read Randomized Trials In Cancer
How to read randomized trials in cancer medicine. Phase 2 vs 3, control arm, crossover, post protocol, censoring (the basics), and how law professors and medical professors are different and why it m…
00:37:48 |
Thu 07 Jul 2022
Lies and Exaggerations about Kids Vaccines < 5 years Old is Bad Public Health
Lies and Exaggerations about Kids Vaccine
I give examples, and show why they are lies
00:19:00 |
Wed 22 Jun 2022
Enact Trial - Enza vs Active Surveillance in Localized Prostate Cancer
What happens when you treat people with $168,000 a year medicine when most of them will never need treatment, and all of them don't need treatment now
00:14:54 |
Mon 20 Jun 2022
Kids Vaccine For Under 5 years Old
I take a deep dive into the data for the mRNA vaccines for kids under 5 years olds
00:42:34 |
Sat 18 Jun 2022
H. Jack West; Lung Cancer; Podcasting; TeleHealth: PACIFIC; ADAURA;CM816: KN189
I sit down with H Jack West. City of Hope. Thoracic Oncology and we have a long discussion about trials; staging; PDL1 thresholds; Driver mutations and post protocol care; ADAURA; Adjuvant; & More
01:17:06 |
Sat 18 Jun 2022
QuANTUM - Quizartinib Front Line - Ethics of Global Trials
I discuss the timeline of Ratify and Quantum. Was this an ethical trial? Is it sufficient to say a trial is ethical because 50% of participants get something?
00:41:46 |
Wed 15 Jun 2022
4.67 Teclistimab for R/R Multiple Myeloma
The drug has a high response rate and lots of infections, is it active? Yes; Efficacious? ???? I review ASCO2022 updates
00:37:42 |
Thu 09 Jun 2022
4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??
Are the results from Luis Diaz as good as touted. What trial should they do going forward?
A 100% CR rate in Stage II and III rectal cancer??
00:24:12 |
Wed 08 Jun 2022
4.65 DESTINY BREAST 04 - A complex trial to deconstruct
My take on the standing ovation for DESTINY Breast 04
Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low
00:32:14 |
Tue 07 Jun 2022
4.64 - DETERMINATION - Should we still use transplant Myeloma?
I break down Richardson, et al. NEJM DETERMINATION
Transplanters are determined to keep going, should they be?
Watch the videos b/c I have lots of great visuals
My ASCO Coverage continues
00:31:53 |
Mon 06 Jun 2022
4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer
The second paper from #ASCO2022 #ASCO22 that I break down
This is one of the most technical papers I breakdown on the channel
CT DNA used to omit chemo in Stage II colon cancer
Read the book Malignan…
00:35:29 |
Sun 05 Jun 2022
4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial
Continuous vs. Fixed, 3 vs 2, PFS is the primary endpoint
No OS
Bad crossover
Lots to discuss here
I will be covering all the major ASCO papers on @PlenarySession
Subscribe to my substack https://vin…
00:18:01 |
Sat 04 Jun 2022
4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis
I am joined by Dr. Katie Sharff, infectious disease doc, to discuss two of her papers on myocarditis after COVID-19 vaccination.
https://doi.org/10.1016/j.amjcard.2022.02.039
https://doi.org/10.1101…
00:54:37 |
Fri 27 May 2022
4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods
I get back to my roots; I explain surrogate validation and a new JCO paper from the FDA authors on EFS and OS in AML. You won't want to miss it
00:34:11 |
Sat 21 May 2022
4.59 - How to be a better reader of case control studies
In this episode I dissect a test negative case control trial; I talk about a famous pancreas cancer study and I revisit the failure of Myeloma trialists
00:18:53 |
Tue 17 May 2022
Disclaimer: The podcast and artwork embedded on this page are the property of Vinay Prasad, MD MPH ([email protected]). This content is not affiliated with or endorsed by eachpod.com.